Local antibiotic delivery vehicles in the treatment of musculoskeletal infection

Clinical Orthopaedics and Related Research

Volumn 437, Issue , 2005, Pages 91-96

  Hanssen, Arlen D ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC CEMENT; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BIOMATERIAL; BONE CEMENT; CALCIUM PHOSPHATE; CALCIUM SULFATE; CEFAZOLIN; CHITOSAN; CIPROFLOXACIN; COLLAGEN; DIMETICONE; GELATIN; GENTAMICIN; GLASS; HYDROXYAPATITE; METHACRYLIC ACID METHYL ESTER; POLY(PROPYLENE GLYCOFUMARATE); POLYANHYDRIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYHYDROXYALKANOIC ACID; POLYHYDROXYBUTYRATE CO HYDROXYVALERATE; POLYLACTIC ACID; POLYMER; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIC ACID DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC THERAPY; BIODEGRADABILITY; BONE GRAFT; BONE MATRIX; BONE PROSTHESIS; BONE REGENERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; DOSE RESPONSE; DRUG DELIVERY SYSTEM; HUMAN; INFECTION; MUSCULOSKELETAL DISEASE; NONHUMAN; ORTHOPEDIC SURGERY; PRIORITY JOURNAL;

EID: 23244434244     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000175713.30506.77     Document Type: Conference Paper

References (63)

1. Ambrose CG, Gogola GR, Clyburn TA, et al: Antibiotic microspheres: Preliminary testing for potential treatment of osteomyelitis. Clin Orthop 415:279-285, 2003.
2. Andreopoulos AG, Korakis T, Dounis E, et al: In vitro release of new quinolones from biodegradable systems: A comparative study. J Biomater Appl 10:338-347, 1996.
3. Becker PL, Smith RA, Williams RS, Dutkowsky JP: Comparison of antibiotic release from polymethylmethacrylate beads and sponge collagen. J Orthop Res 12:737-741, 1994.
4. Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J: Antibiotic-loaded plaster of Paris implants coated with poly lactide-coglycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop 21:403-408, 1997.
5. Booth Jr RE, Lotke PA: The results of spacer block technique in revision of infected total knee arthroplasty. Clin Orthop 248:57-60, 1989.
6. Buchholz HW, Elson RA, Engelbrecht E, et al: Management of deep infection of total hip replacement. J Bone Joint Surg 63B:342-353, 1981.
7. Buranapanitkit B, Srinilta V, Ingviga N, et al: The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. Clin Orthop 424:244-252, 2004.
8. Cierny III G, Mader JT: Approach to adult osteomyelitis. Orthop Rev 16:259-270, 1987.
9. Dash AK, Suryanarayanan R: An implantable dosage form for the treatment of bone infections. Pharm Res 9:993-1002, 1992.
10. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE: Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop 333:245-251, 1996.
11. Frazier DD, Lathi VK, Gerhart TN, Hayes WC: Ex vivo degradation of a poly(propylene glycol-fumarate) biodegradable paniculate composite bone cement. J Biomed Mater Res 35:383-389, 1997.
12. Gitelis S, Brebach GT: The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong) 10:53-60, 2002.
13. Gunasekaran S, Chvapil M: Collagen based biomaterials: An ideal way of increasing their resistance to infection. Biomater Artif Cells Artif Organs 16:771-783, 1988.
14. Haleem AA, Rouse MS, Lewallen DG, et al: Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop 427:22-24, 2004.
15. Hamanishi C, Kitamoto K, Tanaka S, et al: A self-setting TTCP-DCPD apatite cement for release of vancomycin. J Biomed Mater Res 33:139-143, 1996.
16. Hanssen AD: Prophylactic use of antibiotic bone cement: An emerging standard-in opposition. J Arthroplasty 19:73-77, 2004.
17. Hanssen AD, Spangehl MJ: Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop 427:79-85, 2004.
18. Hendricks KJ, Lane D, Burd TA, et al: Elution characteristics of tobramycin from polycaprolactone in a rabbit model. Clin Orthop 392:418-426, 2001.
19. Henry SL, Ostermann PA, Seligson D: The antibiotic bead pouch technique: The management of severe compound fractures. Clin Orthop 295:54-62, 1993.
20. Holtom PD, Pavkovic SA, Bravos PD, et al: Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 18:721-727, 2000.
21. Huang YY, Chung TW: Microencapsulation of gentamicin in biodegradable PLA and/or PLA/PEG copolymer. J Microencapsul 18:457-465, 2001.
22. Huddleston PM, Steckelberg JM, Hanssen AD, et al: Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg 82A:161-173, 2000.
23. Isefuku S, Joyner CJ, Simpson AH: Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma 17:212-216, 2003.
24. Isefuku S, Joyner CJ, Simpson AH: Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res 19:950-954, 2001.
25. Itokazu M, Aoki T, Nonomura H, Nishimoto Y, Itoh Y: Antibiotic-loaded porous hydroxyapatite blocks for the treatment of osteomyelitis and postoperative infection: A preliminary report. Bull Hosp Jt Dis 57:125-129, 1998.
26. Itokazu M, Yamamoto K, Yang WY, et al: The sustained release of antibiotic from freeze-dried fibrin-antibiotic compound and efficacies in a rat model of osteomyelitis. Infection 25:359-363, 1997.
27. Joseph TN, Chen AL, Di Cesare PE: Use of antibiotic-impregnated cement in total joint arthroplasty. J Am Acad Orthop Surg 11:38-47, 2003.
28. Kawanabe K, Okada Y, Matsusue Y, Iida H, Nakamura T: Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg 806:527-530, 1998.
29. Kim HW, Knowles JC, Kim HE: Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res 706:240-249, 2004.
30. Kim K, Luu YK, Chang C, et al: Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)based electrospun nanofibrous scaffolds. J Control Release 98:47-56, 2004.
31. Kumar TR, Vasantha Bai M, Krishnan LK: A freeze-dried fibrin disc as a biodegradable drug release matrix. Biologicals 32:49-55, 2004.
32. Lazarettos J, Efstathopoulos N, Papagelopoulos PJ, et al: A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis. Clin Orthop 423:253-258, 2004.
33. Li LC, Deng J, Stephens D: Polyanhydride implant for antibiotic delivery-From the bench to the clinic. Adv Drug Deliv Rev 54:963-986, 2002.
34. Lindsey RW, Probe R, Miclau T, Alexander JW, Perren SM: The effects of antibiotic-impregnated autogeneic cancellous bone graft on bone healing. Clin Orthop 291:303-312, 1993.
35. Mader JT, Stevens CM, Stevens JH, et al: Treatment of experimental osteomyelitis with a fibrin sealant antibiotic implant. Clin Orthop 403:58-72, 2002.
36. Martins VC, Goissis G, Ribeiro AC, Marcantonio Jr E, Bet MR: The controlled release of antibiotic by hydroxyapatite: Anionic collagen composites. Artif Organs 22:215-221, 1998.
37. McLaren AC: Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop 427:101-106, 2004.
38. Mehta S, Humphrey JS, Schenkman DI, Seaber AV, Vail TP: Gentamicin distribution from a collagen carrier. J Orthop Res 14:749-754, 1996.
39. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE: Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J Orthop Res 16:509-512, 1998.
40. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE: Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 9:401-406, 1995.
41. Mousset B, Benoit MA, Delloye C, Bouillet R, Gillard J: Biodegradable implants for potential use in bone infection: An in vitro study of antibiotic-loaded calcium sulphate. Int Orthop 19:157-161, 1995.
42. Nelson CL: The current status of material used for depot delivery of drugs. Clin Orthop 427:72-78, 2004.
43. Nelson CL, McLaren SG, Skinner RA, et al: The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res 20:643-647, 2002.
44. Otsuka M, Matsuda Y, Kokubo T, et al: A novel skeletal drug delivery system using self-setting bioactive glass bone cement. IV: Cephalexin release from cement containing polymer-coated bulk powder. Biomed Mater Eng 3:229-236, 1993.
45. Park ES, Maniar M, Shah JC: Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: Preparation, and kinetics and mechanism of in vitro release. J Control Release 52:179-189, 1998.
46. Penner MJ, Masri BA, Duncan CP: Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 11:939-944, 1996.
47. Perry AC, Prpa B, Rouse MS, et al: Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop 414:95-100, 2003.
48. Ramchandani M, Robinson D: In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J Control Release 54:167-175, 1998.
49. Rauschmann MA, Wichelhaus TA, Stirnal V, et al: Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26:2677-2684, 2005.
50. Rhyu KH, Jung MH, Yoo JJ, et al: In vitro release of vancomycin from vancomycin-loaded blood coated demineralised bone. Int Orthop 27:53-55, 2003.
51. Rutledge B, Huyette D, Day D, Anglen J: Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer. Clin Orthop 411:280-287, 2003.
52. Schlapp M, Friess W: Collagen/PLGA microparticle composites for local controlled delivery of gentamicin. J Pharm Sci 92:2145-2151, 2003.
53. Shirtliff ME, Calhoun JH, Mader JT: Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin Orthop 401:239-247, 2002.
54. Springer BD, Lee GC, Osmon D, et al: Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop 427:47-51, 2004.
55. Teupe C, Meffert R, Winckler S, et al: Ciprofloxacin-impregnated poly-L-lactic acid drug carrier: New aspects of a resorbable drug delivery system in local antimicrobial treatment of bone infections. Arch Orthop Trauma Surg 112:33-35, 1992.
56. Tsourvakas S, Hatzigrigoris P, Tsibinos A, et al: Pharmacokinetic study of fibrin clot-ciprofloxacin complex: An in vitro and in vivo experimental investigation. Arch Orthop Trauma Surg 114:295-297, 1995.
57. Turesin F, Gursel I, Hasirci V: Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: In vitro antibiotic release. J Biomater Sci Polym Ed 12:195-207, 2001.
58. van Raaij TM, Visser LE, Vulto AG, Verhaar JA: Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty 17:948-950, 2002.
59. Wahlig H: Gentamicin-PMMA beads: A drug delivery system in the treatment of chronic bone and soft tissue infections. J Antimicrob Chemother 10:463-465, 1982.
60. Whiteside LA: Treatment of infected total knee arthroplasty. Clin Orthop 299:169-172, 1994.
61. Woo GL, Yang ML, Yin HQ, et al: Biological characterization of a novel biodegradable antimicrobial polymer synthesized with fluoroquinolones. J Biomed Mater Res 59:35-45, 2002.
62. Yagmurlu MF, Korkusuz F, Gursel I, et al: Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: In vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J Biomed Mater Res 46:494-503, 1999.
63. Yaylaoglu MB, Korkusuz P, Ors U, Korkusuz F, Hasirci V: Development of a calcium phosphate-gelatin composite as a bone substitute and its use in drug release. Biomaterials 20:711-719, 1999.